Diseases Associated With Regulation Of Rhodopsin Mediated Signaling Pathway
Disease |
Cone-Rod Dystrophy 2
|
Csnb1c
|
Retinal Degeneration
|
Marijuana Dependence
|
Phencyclidine Abuse
|
Cocaine Dependence
|
Prolonged Electroretinal Response Suppression
|
Oguchi Disease
|
Diabetes Insipidus, Nephrogenic
|
Diabetes Mellitus, Experimental
|
Disease Models, Animal
|
Dyskinesia, Drug-Induced
|
Fundus Albipunctatus
|
Hypotonia-Cystinuria Syndrome
|
Intestinal Neoplasms
|
Learning Disorders
|
Mitochondrial Myopathies
|
Motor Skills Disorders
|
Muscle Weakness
|
Night Blindness, Congenital Stationary, Autosomal Dominant 1
|
Night Blindness, Congenital Stationary, Autosomal Dominant 2
|
Night Blindness, Congenital Stationary, Autosomal Dominant 3
|
Ovarian Cysts
|
Polyuria
|
Psychoses, Substance-Induced
|
Retinal Cone Dystrophy 2
|
Retinitis Pigmentosa 4
|
Schizophrenia
|
Uveitis
|
Alzheimer's Disease
|
Weight Gain
|
Amaurosis Congenita Of Leber, Type 1
|
Anxiety Disorder
|
Cardiac Hypertrophy
|
Cone Dystrophy 3
|
Cone-Rod Dystrophy 5
|
Unipolar Depression
|
Developmental Disabilities
|